Upgrade to SI Premium - Free Trial

Canaccord Genuity Downgrades STAAR Surgical (STAA) to Hold, Disconcerting Sales Trends

November 1, 2012 8:28 AM
Canaccord Genuity downgraded STAAR Surgical (NASDAQ: STAA) from Buy to Hold with a price target of $7.00 (from $8.25).


(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change Downgrades

Next Articles